BTNL3 and cranioectodermal dysplasia: This hypothesis could explain why the BTNL8*BTNL3 deletion variant, which encodes a BTNL8*3 fusion protein but no full-length BTNL3 or BTNL8 proteins, was not significantly associated with CeD risk in the cohort of 94 samples.